nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupivacaine—CYP1A2—Dacarbazine—pancreatic cancer	0.0855	0.14	CbGbCtD
Bupivacaine—CYP2C19—Tamoxifen—pancreatic cancer	0.0737	0.121	CbGbCtD
Bupivacaine—CYP1A2—Tamoxifen—pancreatic cancer	0.068	0.111	CbGbCtD
Bupivacaine—CYP1A2—Erlotinib—pancreatic cancer	0.0579	0.0947	CbGbCtD
Bupivacaine—CYP2D6—Tamoxifen—pancreatic cancer	0.0561	0.0918	CbGbCtD
Bupivacaine—CYP1A2—Fluorouracil—pancreatic cancer	0.0501	0.0821	CbGbCtD
Bupivacaine—CYP2D6—Erlotinib—pancreatic cancer	0.0477	0.078	CbGbCtD
Bupivacaine—CYP3A4—Tamoxifen—pancreatic cancer	0.0356	0.0583	CbGbCtD
Bupivacaine—CYP3A4—Erlotinib—pancreatic cancer	0.0303	0.0496	CbGbCtD
Bupivacaine—CYP3A4—Irinotecan—pancreatic cancer	0.0274	0.0448	CbGbCtD
Bupivacaine—CYP2D6—Doxorubicin—pancreatic cancer	0.0235	0.0385	CbGbCtD
Bupivacaine—CYP3A4—Docetaxel—pancreatic cancer	0.0201	0.0328	CbGbCtD
Bupivacaine—CYP3A4—Sunitinib—pancreatic cancer	0.02	0.0327	CbGbCtD
Bupivacaine—CYP3A4—Doxorubicin—pancreatic cancer	0.015	0.0245	CbGbCtD
Bupivacaine—Lidocaine—EGFR—pancreatic cancer	0.000907	1	CrCbGaD
Bupivacaine—Arrhythmia—Docetaxel—pancreatic cancer	0.000345	0.00104	CcSEcCtD
Bupivacaine—Dyspnoea—Gemcitabine—pancreatic cancer	0.000345	0.00104	CcSEcCtD
Bupivacaine—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.000344	0.00104	CcSEcCtD
Bupivacaine—Insomnia—Fluorouracil—pancreatic cancer	0.000344	0.00104	CcSEcCtD
Bupivacaine—Somnolence—Gemcitabine—pancreatic cancer	0.000344	0.00104	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000343	0.00103	CcSEcCtD
Bupivacaine—Paraesthesia—Fluorouracil—pancreatic cancer	0.000341	0.00103	CcSEcCtD
Bupivacaine—Pruritus—Sunitinib—pancreatic cancer	0.000341	0.00103	CcSEcCtD
Bupivacaine—Constipation—Irinotecan—pancreatic cancer	0.000339	0.00103	CcSEcCtD
Bupivacaine—Pain—Irinotecan—pancreatic cancer	0.000339	0.00103	CcSEcCtD
Bupivacaine—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.000339	0.00102	CcSEcCtD
Bupivacaine—Dyspnoea—Fluorouracil—pancreatic cancer	0.000339	0.00102	CcSEcCtD
Bupivacaine—Mental disorder—Docetaxel—pancreatic cancer	0.000338	0.00102	CcSEcCtD
Bupivacaine—Somnolence—Fluorouracil—pancreatic cancer	0.000338	0.00102	CcSEcCtD
Bupivacaine—Malnutrition—Docetaxel—pancreatic cancer	0.000336	0.00102	CcSEcCtD
Bupivacaine—Erythema—Docetaxel—pancreatic cancer	0.000336	0.00102	CcSEcCtD
Bupivacaine—Decreased appetite—Gemcitabine—pancreatic cancer	0.000336	0.00102	CcSEcCtD
Bupivacaine—Dyspepsia—Fluorouracil—pancreatic cancer	0.000335	0.00101	CcSEcCtD
Bupivacaine—Nausea—Tamoxifen—pancreatic cancer	0.000334	0.00101	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000334	0.00101	CcSEcCtD
Bupivacaine—Muscular weakness—Epirubicin—pancreatic cancer	0.000332	0.001	CcSEcCtD
Bupivacaine—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000332	0.001	CcSEcCtD
Bupivacaine—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000331	0.001	CcSEcCtD
Bupivacaine—Constipation—Gemcitabine—pancreatic cancer	0.000331	0.000999	CcSEcCtD
Bupivacaine—Pain—Gemcitabine—pancreatic cancer	0.000331	0.000999	CcSEcCtD
Bupivacaine—Nausea—Erlotinib—pancreatic cancer	0.000331	0.000999	CcSEcCtD
Bupivacaine—Decreased appetite—Fluorouracil—pancreatic cancer	0.00033	0.000998	CcSEcCtD
Bupivacaine—Diarrhoea—Sunitinib—pancreatic cancer	0.00033	0.000996	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000328	0.000991	CcSEcCtD
Bupivacaine—Abdominal distension—Epirubicin—pancreatic cancer	0.000328	0.000989	CcSEcCtD
Bupivacaine—Feeling abnormal—Irinotecan—pancreatic cancer	0.000327	0.000988	CcSEcCtD
Bupivacaine—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000326	0.000986	CcSEcCtD
Bupivacaine—Dysphagia—Epirubicin—pancreatic cancer	0.000325	0.000983	CcSEcCtD
Bupivacaine—Back pain—Docetaxel—pancreatic cancer	0.000325	0.000982	CcSEcCtD
Bupivacaine—Pain—Fluorouracil—pancreatic cancer	0.000325	0.000982	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000325	0.00098	CcSEcCtD
Bupivacaine—Muscle spasms—Docetaxel—pancreatic cancer	0.000323	0.000976	CcSEcCtD
Bupivacaine—Dizziness—Sunitinib—pancreatic cancer	0.000319	0.000962	CcSEcCtD
Bupivacaine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000319	0.000962	CcSEcCtD
Bupivacaine—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000318	0.000961	CcSEcCtD
Bupivacaine—Abdominal pain—Irinotecan—pancreatic cancer	0.000314	0.000948	CcSEcCtD
Bupivacaine—Body temperature increased—Irinotecan—pancreatic cancer	0.000314	0.000948	CcSEcCtD
Bupivacaine—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000314	0.000948	CcSEcCtD
Bupivacaine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000313	0.000946	CcSEcCtD
Bupivacaine—Anaemia—Docetaxel—pancreatic cancer	0.000311	0.000938	CcSEcCtD
Bupivacaine—Muscular weakness—Doxorubicin—pancreatic cancer	0.000307	0.000928	CcSEcCtD
Bupivacaine—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000307	0.000928	CcSEcCtD
Bupivacaine—Vomiting—Sunitinib—pancreatic cancer	0.000306	0.000925	CcSEcCtD
Bupivacaine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000306	0.000923	CcSEcCtD
Bupivacaine—Abdominal distension—Doxorubicin—pancreatic cancer	0.000303	0.000916	CcSEcCtD
Bupivacaine—Urticaria—Fluorouracil—pancreatic cancer	0.000302	0.000912	CcSEcCtD
Bupivacaine—Headache—Sunitinib—pancreatic cancer	0.000302	0.000912	CcSEcCtD
Bupivacaine—Syncope—Docetaxel—pancreatic cancer	0.000301	0.000911	CcSEcCtD
Bupivacaine—Dysphagia—Doxorubicin—pancreatic cancer	0.000301	0.000909	CcSEcCtD
Bupivacaine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000301	0.000908	CcSEcCtD
Bupivacaine—Palpitations—Docetaxel—pancreatic cancer	0.000297	0.000897	CcSEcCtD
Bupivacaine—Loss of consciousness—Docetaxel—pancreatic cancer	0.000295	0.000892	CcSEcCtD
Bupivacaine—Cough—Docetaxel—pancreatic cancer	0.000293	0.000886	CcSEcCtD
Bupivacaine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000292	0.000883	CcSEcCtD
Bupivacaine—Convulsion—Docetaxel—pancreatic cancer	0.000291	0.00088	CcSEcCtD
Bupivacaine—Hypertension—Docetaxel—pancreatic cancer	0.00029	0.000877	CcSEcCtD
Bupivacaine—Infestation—Epirubicin—pancreatic cancer	0.00029	0.000876	CcSEcCtD
Bupivacaine—Infestation NOS—Epirubicin—pancreatic cancer	0.00029	0.000876	CcSEcCtD
Bupivacaine—Drowsiness—Epirubicin—pancreatic cancer	0.00029	0.000876	CcSEcCtD
Bupivacaine—Arthralgia—Docetaxel—pancreatic cancer	0.000286	0.000864	CcSEcCtD
Bupivacaine—Nausea—Sunitinib—pancreatic cancer	0.000286	0.000864	CcSEcCtD
Bupivacaine—Asthenia—Irinotecan—pancreatic cancer	0.000285	0.00086	CcSEcCtD
Bupivacaine—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000284	0.000859	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000284	0.000858	CcSEcCtD
Bupivacaine—Urinary tract infection—Epirubicin—pancreatic cancer	0.000282	0.000852	CcSEcCtD
Bupivacaine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00028	0.000846	CcSEcCtD
Bupivacaine—Sweating—Epirubicin—pancreatic cancer	0.000278	0.00084	CcSEcCtD
Bupivacaine—Asthenia—Gemcitabine—pancreatic cancer	0.000277	0.000838	CcSEcCtD
Bupivacaine—Haematuria—Epirubicin—pancreatic cancer	0.000277	0.000836	CcSEcCtD
Bupivacaine—Confusional state—Docetaxel—pancreatic cancer	0.000277	0.000836	CcSEcCtD
Bupivacaine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000274	0.000829	CcSEcCtD
Bupivacaine—Oedema—Docetaxel—pancreatic cancer	0.000274	0.000829	CcSEcCtD
Bupivacaine—Pruritus—Gemcitabine—pancreatic cancer	0.000274	0.000826	CcSEcCtD
Bupivacaine—Infection—Docetaxel—pancreatic cancer	0.000273	0.000823	CcSEcCtD
Bupivacaine—Diarrhoea—Irinotecan—pancreatic cancer	0.000272	0.00082	CcSEcCtD
Bupivacaine—Shock—Docetaxel—pancreatic cancer	0.00027	0.000815	CcSEcCtD
Bupivacaine—Nervous system disorder—Docetaxel—pancreatic cancer	0.000269	0.000813	CcSEcCtD
Bupivacaine—Pruritus—Fluorouracil—pancreatic cancer	0.000269	0.000812	CcSEcCtD
Bupivacaine—Infestation—Doxorubicin—pancreatic cancer	0.000268	0.000811	CcSEcCtD
Bupivacaine—Drowsiness—Doxorubicin—pancreatic cancer	0.000268	0.000811	CcSEcCtD
Bupivacaine—Infestation NOS—Doxorubicin—pancreatic cancer	0.000268	0.000811	CcSEcCtD
Bupivacaine—Tachycardia—Docetaxel—pancreatic cancer	0.000268	0.000809	CcSEcCtD
Bupivacaine—Skin disorder—Docetaxel—pancreatic cancer	0.000267	0.000805	CcSEcCtD
Bupivacaine—Bradycardia—Epirubicin—pancreatic cancer	0.000265	0.000801	CcSEcCtD
Bupivacaine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000265	0.000799	CcSEcCtD
Bupivacaine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000263	0.000795	CcSEcCtD
Bupivacaine—Dizziness—Irinotecan—pancreatic cancer	0.000262	0.000793	CcSEcCtD
Bupivacaine—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000261	0.000788	CcSEcCtD
Bupivacaine—Diarrhoea—Fluorouracil—pancreatic cancer	0.00026	0.000786	CcSEcCtD
Bupivacaine—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000259	0.000783	CcSEcCtD
Bupivacaine—Sweating—Doxorubicin—pancreatic cancer	0.000257	0.000777	CcSEcCtD
Bupivacaine—Oedema peripheral—Epirubicin—pancreatic cancer	0.000257	0.000775	CcSEcCtD
Bupivacaine—Hypotension—Docetaxel—pancreatic cancer	0.000256	0.000774	CcSEcCtD
Bupivacaine—Haematuria—Doxorubicin—pancreatic cancer	0.000256	0.000773	CcSEcCtD
Bupivacaine—Vomiting—Irinotecan—pancreatic cancer	0.000252	0.000762	CcSEcCtD
Bupivacaine—Dizziness—Fluorouracil—pancreatic cancer	0.000251	0.000759	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00025	0.000755	CcSEcCtD
Bupivacaine—Headache—Irinotecan—pancreatic cancer	0.000249	0.000751	CcSEcCtD
Bupivacaine—Insomnia—Docetaxel—pancreatic cancer	0.000248	0.000749	CcSEcCtD
Bupivacaine—Paraesthesia—Docetaxel—pancreatic cancer	0.000246	0.000744	CcSEcCtD
Bupivacaine—Vomiting—Gemcitabine—pancreatic cancer	0.000246	0.000742	CcSEcCtD
Bupivacaine—Bradycardia—Doxorubicin—pancreatic cancer	0.000245	0.000741	CcSEcCtD
Bupivacaine—Dyspnoea—Docetaxel—pancreatic cancer	0.000245	0.000739	CcSEcCtD
Bupivacaine—Somnolence—Docetaxel—pancreatic cancer	0.000244	0.000737	CcSEcCtD
Bupivacaine—Tinnitus—Epirubicin—pancreatic cancer	0.000243	0.000734	CcSEcCtD
Bupivacaine—Headache—Gemcitabine—pancreatic cancer	0.000242	0.000732	CcSEcCtD
Bupivacaine—Flushing—Epirubicin—pancreatic cancer	0.000242	0.00073	CcSEcCtD
Bupivacaine—Cardiac disorder—Epirubicin—pancreatic cancer	0.000242	0.00073	CcSEcCtD
Bupivacaine—Vomiting—Fluorouracil—pancreatic cancer	0.000242	0.00073	CcSEcCtD
Bupivacaine—Dyspepsia—Docetaxel—pancreatic cancer	0.000242	0.000729	CcSEcCtD
Bupivacaine—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.00024	0.000724	CcSEcCtD
Bupivacaine—Decreased appetite—Docetaxel—pancreatic cancer	0.000239	0.00072	CcSEcCtD
Bupivacaine—Headache—Fluorouracil—pancreatic cancer	0.000238	0.000719	CcSEcCtD
Bupivacaine—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000237	0.000717	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000237	0.000715	CcSEcCtD
Bupivacaine—Nausea—Irinotecan—pancreatic cancer	0.000236	0.000712	CcSEcCtD
Bupivacaine—Constipation—Docetaxel—pancreatic cancer	0.000235	0.000709	CcSEcCtD
Bupivacaine—Pain—Docetaxel—pancreatic cancer	0.000235	0.000709	CcSEcCtD
Bupivacaine—Chills—Epirubicin—pancreatic cancer	0.000234	0.000706	CcSEcCtD
Bupivacaine—Arrhythmia—Epirubicin—pancreatic cancer	0.000233	0.000703	CcSEcCtD
Bupivacaine—Nausea—Gemcitabine—pancreatic cancer	0.00023	0.000694	CcSEcCtD
Bupivacaine—Mental disorder—Epirubicin—pancreatic cancer	0.000228	0.000689	CcSEcCtD
Bupivacaine—Malnutrition—Epirubicin—pancreatic cancer	0.000227	0.000685	CcSEcCtD
Bupivacaine—Erythema—Epirubicin—pancreatic cancer	0.000227	0.000685	CcSEcCtD
Bupivacaine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000226	0.000683	CcSEcCtD
Bupivacaine—Nausea—Fluorouracil—pancreatic cancer	0.000226	0.000682	CcSEcCtD
Bupivacaine—Tinnitus—Doxorubicin—pancreatic cancer	0.000225	0.000679	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000224	0.000678	CcSEcCtD
Bupivacaine—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000224	0.000676	CcSEcCtD
Bupivacaine—Flushing—Doxorubicin—pancreatic cancer	0.000224	0.000676	CcSEcCtD
Bupivacaine—Flatulence—Epirubicin—pancreatic cancer	0.000223	0.000675	CcSEcCtD
Bupivacaine—Tension—Epirubicin—pancreatic cancer	0.000223	0.000672	CcSEcCtD
Bupivacaine—Nervousness—Epirubicin—pancreatic cancer	0.00022	0.000665	CcSEcCtD
Bupivacaine—Back pain—Epirubicin—pancreatic cancer	0.000219	0.000662	CcSEcCtD
Bupivacaine—Muscle spasms—Epirubicin—pancreatic cancer	0.000218	0.000658	CcSEcCtD
Bupivacaine—Body temperature increased—Docetaxel—pancreatic cancer	0.000217	0.000655	CcSEcCtD
Bupivacaine—Abdominal pain—Docetaxel—pancreatic cancer	0.000217	0.000655	CcSEcCtD
Bupivacaine—Chills—Doxorubicin—pancreatic cancer	0.000216	0.000653	CcSEcCtD
Bupivacaine—Arrhythmia—Doxorubicin—pancreatic cancer	0.000215	0.00065	CcSEcCtD
Bupivacaine—Vision blurred—Epirubicin—pancreatic cancer	0.000214	0.000645	CcSEcCtD
Bupivacaine—Mental disorder—Doxorubicin—pancreatic cancer	0.000211	0.000638	CcSEcCtD
Bupivacaine—Erythema—Doxorubicin—pancreatic cancer	0.00021	0.000634	CcSEcCtD
Bupivacaine—Malnutrition—Doxorubicin—pancreatic cancer	0.00021	0.000634	CcSEcCtD
Bupivacaine—Anaemia—Epirubicin—pancreatic cancer	0.00021	0.000633	CcSEcCtD
Bupivacaine—Agitation—Epirubicin—pancreatic cancer	0.000208	0.000629	CcSEcCtD
Bupivacaine—Flatulence—Doxorubicin—pancreatic cancer	0.000207	0.000624	CcSEcCtD
Bupivacaine—Tension—Doxorubicin—pancreatic cancer	0.000206	0.000622	CcSEcCtD
Bupivacaine—Nervousness—Doxorubicin—pancreatic cancer	0.000204	0.000615	CcSEcCtD
Bupivacaine—Syncope—Epirubicin—pancreatic cancer	0.000203	0.000614	CcSEcCtD
Bupivacaine—Back pain—Doxorubicin—pancreatic cancer	0.000203	0.000613	CcSEcCtD
Bupivacaine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000202	0.000611	CcSEcCtD
Bupivacaine—Muscle spasms—Doxorubicin—pancreatic cancer	0.000202	0.000609	CcSEcCtD
Bupivacaine—Palpitations—Epirubicin—pancreatic cancer	0.0002	0.000605	CcSEcCtD
Bupivacaine—Loss of consciousness—Epirubicin—pancreatic cancer	0.000199	0.000602	CcSEcCtD
Bupivacaine—Cough—Epirubicin—pancreatic cancer	0.000198	0.000598	CcSEcCtD
Bupivacaine—Vision blurred—Doxorubicin—pancreatic cancer	0.000198	0.000597	CcSEcCtD
Bupivacaine—Asthenia—Docetaxel—pancreatic cancer	0.000197	0.000595	CcSEcCtD
Bupivacaine—Convulsion—Epirubicin—pancreatic cancer	0.000196	0.000593	CcSEcCtD
Bupivacaine—Hypertension—Epirubicin—pancreatic cancer	0.000196	0.000591	CcSEcCtD
Bupivacaine—Pruritus—Docetaxel—pancreatic cancer	0.000194	0.000586	CcSEcCtD
Bupivacaine—Anaemia—Doxorubicin—pancreatic cancer	0.000194	0.000586	CcSEcCtD
Bupivacaine—Arthralgia—Epirubicin—pancreatic cancer	0.000193	0.000583	CcSEcCtD
Bupivacaine—Agitation—Doxorubicin—pancreatic cancer	0.000193	0.000582	CcSEcCtD
Bupivacaine—Anxiety—Epirubicin—pancreatic cancer	0.000192	0.000581	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000192	0.000579	CcSEcCtD
Bupivacaine—Syncope—Doxorubicin—pancreatic cancer	0.000188	0.000568	CcSEcCtD
Bupivacaine—Diarrhoea—Docetaxel—pancreatic cancer	0.000188	0.000567	CcSEcCtD
Bupivacaine—Confusional state—Epirubicin—pancreatic cancer	0.000187	0.000564	CcSEcCtD
Bupivacaine—Palpitations—Doxorubicin—pancreatic cancer	0.000185	0.00056	CcSEcCtD
Bupivacaine—Oedema—Epirubicin—pancreatic cancer	0.000185	0.000559	CcSEcCtD
Bupivacaine—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000185	0.000559	CcSEcCtD
Bupivacaine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000184	0.000557	CcSEcCtD
Bupivacaine—Infection—Epirubicin—pancreatic cancer	0.000184	0.000555	CcSEcCtD
Bupivacaine—Cough—Doxorubicin—pancreatic cancer	0.000183	0.000553	CcSEcCtD
Bupivacaine—Shock—Epirubicin—pancreatic cancer	0.000182	0.00055	CcSEcCtD
Bupivacaine—Convulsion—Doxorubicin—pancreatic cancer	0.000182	0.000549	CcSEcCtD
Bupivacaine—Nervous system disorder—Epirubicin—pancreatic cancer	0.000181	0.000548	CcSEcCtD
Bupivacaine—Dizziness—Docetaxel—pancreatic cancer	0.000181	0.000548	CcSEcCtD
Bupivacaine—Hypertension—Doxorubicin—pancreatic cancer	0.000181	0.000547	CcSEcCtD
Bupivacaine—Tachycardia—Epirubicin—pancreatic cancer	0.000181	0.000545	CcSEcCtD
Bupivacaine—Skin disorder—Epirubicin—pancreatic cancer	0.00018	0.000543	CcSEcCtD
Bupivacaine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000179	0.00054	CcSEcCtD
Bupivacaine—Arthralgia—Doxorubicin—pancreatic cancer	0.000179	0.000539	CcSEcCtD
Bupivacaine—Anxiety—Doxorubicin—pancreatic cancer	0.000178	0.000538	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000177	0.000536	CcSEcCtD
Bupivacaine—Vomiting—Docetaxel—pancreatic cancer	0.000174	0.000527	CcSEcCtD
Bupivacaine—Hypotension—Epirubicin—pancreatic cancer	0.000173	0.000522	CcSEcCtD
Bupivacaine—Confusional state—Doxorubicin—pancreatic cancer	0.000173	0.000521	CcSEcCtD
Bupivacaine—Headache—Docetaxel—pancreatic cancer	0.000172	0.000519	CcSEcCtD
Bupivacaine—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000171	0.000517	CcSEcCtD
Bupivacaine—Oedema—Doxorubicin—pancreatic cancer	0.000171	0.000517	CcSEcCtD
Bupivacaine—Infection—Doxorubicin—pancreatic cancer	0.00017	0.000514	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000169	0.000509	CcSEcCtD
Bupivacaine—Shock—Doxorubicin—pancreatic cancer	0.000168	0.000509	CcSEcCtD
Bupivacaine—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000168	0.000507	CcSEcCtD
Bupivacaine—Insomnia—Epirubicin—pancreatic cancer	0.000167	0.000506	CcSEcCtD
Bupivacaine—Tachycardia—Doxorubicin—pancreatic cancer	0.000167	0.000505	CcSEcCtD
Bupivacaine—Skin disorder—Doxorubicin—pancreatic cancer	0.000166	0.000502	CcSEcCtD
Bupivacaine—Paraesthesia—Epirubicin—pancreatic cancer	0.000166	0.000502	CcSEcCtD
Bupivacaine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000166	0.0005	CcSEcCtD
Bupivacaine—Dyspnoea—Epirubicin—pancreatic cancer	0.000165	0.000498	CcSEcCtD
Bupivacaine—Somnolence—Epirubicin—pancreatic cancer	0.000165	0.000497	CcSEcCtD
Bupivacaine—Nausea—Docetaxel—pancreatic cancer	0.000163	0.000492	CcSEcCtD
Bupivacaine—Dyspepsia—Epirubicin—pancreatic cancer	0.000163	0.000492	CcSEcCtD
Bupivacaine—Decreased appetite—Epirubicin—pancreatic cancer	0.000161	0.000486	CcSEcCtD
Bupivacaine—Hypotension—Doxorubicin—pancreatic cancer	0.00016	0.000483	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.00016	0.000483	CcSEcCtD
Bupivacaine—Constipation—Epirubicin—pancreatic cancer	0.000158	0.000478	CcSEcCtD
Bupivacaine—Pain—Epirubicin—pancreatic cancer	0.000158	0.000478	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000156	0.000471	CcSEcCtD
Bupivacaine—Insomnia—Doxorubicin—pancreatic cancer	0.000155	0.000468	CcSEcCtD
Bupivacaine—Paraesthesia—Doxorubicin—pancreatic cancer	0.000154	0.000464	CcSEcCtD
Bupivacaine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000153	0.000461	CcSEcCtD
Bupivacaine—Feeling abnormal—Epirubicin—pancreatic cancer	0.000153	0.000461	CcSEcCtD
Bupivacaine—Somnolence—Doxorubicin—pancreatic cancer	0.000152	0.00046	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000151	0.000457	CcSEcCtD
Bupivacaine—Dyspepsia—Doxorubicin—pancreatic cancer	0.000151	0.000455	CcSEcCtD
Bupivacaine—Decreased appetite—Doxorubicin—pancreatic cancer	0.000149	0.00045	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000148	0.000446	CcSEcCtD
Bupivacaine—Urticaria—Epirubicin—pancreatic cancer	0.000147	0.000444	CcSEcCtD
Bupivacaine—Pain—Doxorubicin—pancreatic cancer	0.000146	0.000442	CcSEcCtD
Bupivacaine—Constipation—Doxorubicin—pancreatic cancer	0.000146	0.000442	CcSEcCtD
Bupivacaine—Abdominal pain—Epirubicin—pancreatic cancer	0.000146	0.000442	CcSEcCtD
Bupivacaine—Body temperature increased—Epirubicin—pancreatic cancer	0.000146	0.000442	CcSEcCtD
Bupivacaine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000141	0.000426	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.00014	0.000423	CcSEcCtD
Bupivacaine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000136	0.000412	CcSEcCtD
Bupivacaine—Urticaria—Doxorubicin—pancreatic cancer	0.000136	0.000411	CcSEcCtD
Bupivacaine—Body temperature increased—Doxorubicin—pancreatic cancer	0.000135	0.000409	CcSEcCtD
Bupivacaine—Abdominal pain—Doxorubicin—pancreatic cancer	0.000135	0.000409	CcSEcCtD
Bupivacaine—Asthenia—Epirubicin—pancreatic cancer	0.000133	0.000401	CcSEcCtD
Bupivacaine—Pruritus—Epirubicin—pancreatic cancer	0.000131	0.000395	CcSEcCtD
Bupivacaine—Diarrhoea—Epirubicin—pancreatic cancer	0.000127	0.000382	CcSEcCtD
Bupivacaine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000126	0.000381	CcSEcCtD
Bupivacaine—Asthenia—Doxorubicin—pancreatic cancer	0.000123	0.000371	CcSEcCtD
Bupivacaine—Dizziness—Epirubicin—pancreatic cancer	0.000122	0.00037	CcSEcCtD
Bupivacaine—Pruritus—Doxorubicin—pancreatic cancer	0.000121	0.000366	CcSEcCtD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—RB1—pancreatic cancer	0.000118	0.00207	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—PTHLH—pancreatic cancer	0.000118	0.00207	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—PTCH1—pancreatic cancer	0.000118	0.00207	CbGpPWpGaD
Bupivacaine—Vomiting—Epirubicin—pancreatic cancer	0.000118	0.000355	CcSEcCtD
Bupivacaine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000117	0.000354	CcSEcCtD
Bupivacaine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	0.000117	0.00205	CbGpPWpGaD
Bupivacaine—CYP2C19—Arachidonic acid metabolism—PTGS2—pancreatic cancer	0.000117	0.00205	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—SSTR1—pancreatic cancer	0.000117	0.00204	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—KDR—pancreatic cancer	0.000116	0.00204	CbGpPWpGaD
Bupivacaine—Headache—Epirubicin—pancreatic cancer	0.000116	0.00035	CcSEcCtD
Bupivacaine—PTGER1—Signaling Pathways—PPY—pancreatic cancer	0.000114	0.002	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—MET—pancreatic cancer	0.000114	0.002	CbGpPWpGaD
Bupivacaine—Dizziness—Doxorubicin—pancreatic cancer	0.000113	0.000342	CcSEcCtD
Bupivacaine—PTGER1—Signaling Pathways—SSTR2—pancreatic cancer	0.000112	0.00197	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—KDR—pancreatic cancer	0.000112	0.00197	CbGpPWpGaD
Bupivacaine—Nausea—Epirubicin—pancreatic cancer	0.00011	0.000332	CcSEcCtD
Bupivacaine—PTGER1—GPCR downstream signaling—CNR1—pancreatic cancer	0.00011	0.00193	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—MET—pancreatic cancer	0.00011	0.00193	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—NOTCH1—pancreatic cancer	0.00011	0.00192	CbGpPWpGaD
Bupivacaine—Vomiting—Doxorubicin—pancreatic cancer	0.000109	0.000329	CcSEcCtD
Bupivacaine—PTGER1—Signaling Pathways—CCKBR—pancreatic cancer	0.000108	0.0019	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—SST—pancreatic cancer	0.000108	0.0019	CbGpPWpGaD
Bupivacaine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000108	0.00189	CbGpPWpGaD
Bupivacaine—Headache—Doxorubicin—pancreatic cancer	0.000107	0.000324	CcSEcCtD
Bupivacaine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	0.000106	0.00187	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—GCG—pancreatic cancer	0.000106	0.00186	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—NOTCH1—pancreatic cancer	0.000106	0.00185	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—PPARG—pancreatic cancer	0.000103	0.00181	CbGpPWpGaD
Bupivacaine—PTGER1—G alpha (q) signalling events—PIK3CA—pancreatic cancer	0.000103	0.00181	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—DTX4—pancreatic cancer	0.000102	0.00179	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—GLI1—pancreatic cancer	0.000102	0.00179	CbGpPWpGaD
Bupivacaine—Nausea—Doxorubicin—pancreatic cancer	0.000102	0.000307	CcSEcCtD
Bupivacaine—PTGER1—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000101	0.00178	CbGpPWpGaD
Bupivacaine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	0.000101	0.00176	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—MMP9—pancreatic cancer	0.0001	0.00175	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—CNR1—pancreatic cancer	9.98e-05	0.00175	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—PPARG—pancreatic cancer	9.98e-05	0.00175	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PPP2R5B—pancreatic cancer	9.91e-05	0.00174	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—NRP1—pancreatic cancer	9.91e-05	0.00174	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—pancreatic cancer	9.72e-05	0.00171	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—MMP9—pancreatic cancer	9.65e-05	0.00169	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—GCG—pancreatic cancer	9.64e-05	0.00169	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—HEY2—pancreatic cancer	9.54e-05	0.00167	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—MMP2—pancreatic cancer	9.5e-05	0.00167	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—GAST—pancreatic cancer	9.32e-05	0.00163	CbGpPWpGaD
Bupivacaine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	9.24e-05	0.00162	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—SRC—pancreatic cancer	9.22e-05	0.00162	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—AGTR1—pancreatic cancer	9.2e-05	0.00161	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—MMP2—pancreatic cancer	9.16e-05	0.00161	CbGpPWpGaD
Bupivacaine—CYP1A2—Arachidonic acid metabolism—PTGS2—pancreatic cancer	9.1e-05	0.0016	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—VEGFA—pancreatic cancer	8.98e-05	0.00158	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—SRC—pancreatic cancer	8.9e-05	0.00156	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—NRAS—pancreatic cancer	8.87e-05	0.00156	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—SCT—pancreatic cancer	8.84e-05	0.00155	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—HEY1—pancreatic cancer	8.84e-05	0.00155	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—VEGFA—pancreatic cancer	8.66e-05	0.00152	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—NRAS—pancreatic cancer	8.56e-05	0.0015	CbGpPWpGaD
Bupivacaine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	8.54e-05	0.0015	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CCK—pancreatic cancer	8.43e-05	0.00148	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CNR2—pancreatic cancer	8.21e-05	0.00144	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—GLP1R—pancreatic cancer	8.21e-05	0.00144	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—CXCL8—pancreatic cancer	8.21e-05	0.00144	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—EGFR—pancreatic cancer	8.09e-05	0.00142	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CCKAR—pancreatic cancer	8.08e-05	0.00142	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—pancreatic cancer	7.86e-05	0.00138	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—SRC—pancreatic cancer	7.86e-05	0.00138	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—JAG2—pancreatic cancer	7.84e-05	0.00137	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—EGFR—pancreatic cancer	7.8e-05	0.00137	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MEN1—pancreatic cancer	7.72e-05	0.00135	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—pancreatic cancer	7.66e-05	0.00134	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—KRAS—pancreatic cancer	7.64e-05	0.00134	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—pancreatic cancer	7.57e-05	0.00133	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—SHH—pancreatic cancer	7.37e-05	0.00129	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—KRAS—pancreatic cancer	7.37e-05	0.00129	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—NOTCH4—pancreatic cancer	7.32e-05	0.00128	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—CTNNB1—pancreatic cancer	7.28e-05	0.00128	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—IAPP—pancreatic cancer	7.28e-05	0.00128	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—MMP9—pancreatic cancer	7.14e-05	0.00125	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—pancreatic cancer	7.05e-05	0.00124	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—pancreatic cancer	7.03e-05	0.00123	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—CTNNB1—pancreatic cancer	7.02e-05	0.00123	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PTHLH—pancreatic cancer	6.98e-05	0.00122	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PTCH1—pancreatic cancer	6.98e-05	0.00122	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pancreatic cancer	6.89e-05	0.00121	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pancreatic cancer	6.89e-05	0.00121	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—MMP9—pancreatic cancer	6.88e-05	0.00121	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—SRC—pancreatic cancer	6.58e-05	0.00115	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—pancreatic cancer	6.56e-05	0.00115	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—pancreatic cancer	6.56e-05	0.00115	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—pancreatic cancer	6.51e-05	0.00114	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—HRAS—pancreatic cancer	6.49e-05	0.00114	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—VEGFA—pancreatic cancer	6.41e-05	0.00112	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—SST—pancreatic cancer	6.39e-05	0.00112	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—STAT3—pancreatic cancer	6.35e-05	0.00111	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—SRC—pancreatic cancer	6.35e-05	0.00111	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—NRAS—pancreatic cancer	6.33e-05	0.00111	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—PIK3CG—pancreatic cancer	6.3e-05	0.0011	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—HRAS—pancreatic cancer	6.26e-05	0.0011	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—JAG1—pancreatic cancer	6.25e-05	0.0011	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—NOTCH3—pancreatic cancer	6.23e-05	0.00109	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—VEGFA—pancreatic cancer	6.18e-05	0.00108	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—STAT3—pancreatic cancer	6.12e-05	0.00107	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—NRAS—pancreatic cancer	6.11e-05	0.00107	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CNR1—pancreatic cancer	5.9e-05	0.00103	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—TGFB1—pancreatic cancer	5.88e-05	0.00103	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—EGFR—pancreatic cancer	5.77e-05	0.00101	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—PIK3CG—pancreatic cancer	5.72e-05	0.001	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—GCG—pancreatic cancer	5.69e-05	0.000998	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—TGFB1—pancreatic cancer	5.67e-05	0.000995	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—EGFR—pancreatic cancer	5.56e-05	0.000976	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—PIK3CD—pancreatic cancer	5.54e-05	0.000971	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—pancreatic cancer	5.54e-05	0.000971	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—TNF—pancreatic cancer	5.49e-05	0.000964	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—KRAS—pancreatic cancer	5.45e-05	0.000956	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—AGTR1—pancreatic cancer	5.43e-05	0.000952	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—STK11—pancreatic cancer	5.35e-05	0.000939	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—TNF—pancreatic cancer	5.3e-05	0.000929	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—KRAS—pancreatic cancer	5.26e-05	0.000922	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—PIK3CD—pancreatic cancer	5.03e-05	0.000882	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—PIK3CB—pancreatic cancer	4.83e-05	0.000847	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—SMAD4—pancreatic cancer	4.69e-05	0.000822	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—CXCL8—pancreatic cancer	4.64e-05	0.000814	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—HRAS—pancreatic cancer	4.63e-05	0.000812	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—HES1—pancreatic cancer	4.58e-05	0.000803	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—HRAS—pancreatic cancer	4.47e-05	0.000783	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—PIK3CB—pancreatic cancer	4.38e-05	0.000769	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—CXCL8—pancreatic cancer	4.21e-05	0.000739	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—AKT1—pancreatic cancer	4.09e-05	0.000717	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—TERT—pancreatic cancer	4.01e-05	0.000703	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—AKT1—pancreatic cancer	3.94e-05	0.000692	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PRSS1—pancreatic cancer	3.89e-05	0.000683	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—HIF1A—pancreatic cancer	3.84e-05	0.000673	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—TSC2—pancreatic cancer	3.83e-05	0.000671	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—APOE—pancreatic cancer	3.75e-05	0.000657	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—KDR—pancreatic cancer	3.67e-05	0.000643	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PRSS1—pancreatic cancer	3.58e-05	0.000628	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—NFKBIA—pancreatic cancer	3.49e-05	0.000612	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—NOTCH1—pancreatic cancer	3.46e-05	0.000606	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PIK3CG—pancreatic cancer	3.38e-05	0.000593	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—NRAS—pancreatic cancer	3.38e-05	0.000593	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ARG2—pancreatic cancer	3.38e-05	0.000592	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—EGF—pancreatic cancer	3.34e-05	0.000586	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ARG2—pancreatic cancer	3.11e-05	0.000544	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—EGFR—pancreatic cancer	3.08e-05	0.00054	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PRSS1—pancreatic cancer	3.03e-05	0.000532	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PIK3CD—pancreatic cancer	2.97e-05	0.000521	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—TYMP—pancreatic cancer	2.95e-05	0.000517	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.94e-05	0.000516	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—KRAS—pancreatic cancer	2.91e-05	0.00051	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—TYMP—pancreatic cancer	2.71e-05	0.000476	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—PIK3CA—pancreatic cancer	2.67e-05	0.000469	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ARG2—pancreatic cancer	2.63e-05	0.000461	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PIK3CB—pancreatic cancer	2.59e-05	0.000454	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CXCL8—pancreatic cancer	2.49e-05	0.000436	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—HRAS—pancreatic cancer	2.47e-05	0.000434	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.44e-05	0.000427	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—AKT1—pancreatic cancer	2.4e-05	0.000422	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CASP3—pancreatic cancer	2.38e-05	0.000418	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GLP1R—pancreatic cancer	2.38e-05	0.000417	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PRSS1—pancreatic cancer	2.34e-05	0.000411	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—DPYD—pancreatic cancer	2.34e-05	0.00041	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CCND1—pancreatic cancer	2.32e-05	0.000407	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—TYMP—pancreatic cancer	2.3e-05	0.000403	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CTNNB1—pancreatic cancer	2.3e-05	0.000403	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MMP9—pancreatic cancer	2.25e-05	0.000395	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PTEN—pancreatic cancer	2.24e-05	0.000392	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	2.22e-05	0.000389	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.2e-05	0.000385	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GLP1R—pancreatic cancer	2.19e-05	0.000384	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—AKT1—pancreatic cancer	2.18e-05	0.000383	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—DPYD—pancreatic cancer	2.15e-05	0.000377	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.12e-05	0.000372	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—SRC—pancreatic cancer	2.08e-05	0.000364	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	2.04e-05	0.000358	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ARG2—pancreatic cancer	2.03e-05	0.000356	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—VEGFA—pancreatic cancer	2.02e-05	0.000354	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—STAT3—pancreatic cancer	2e-05	0.000351	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—NRAS—pancreatic cancer	2e-05	0.00035	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.93e-05	0.000339	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.9e-05	0.000333	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MYC—pancreatic cancer	1.86e-05	0.000326	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—TGFB1—pancreatic cancer	1.86e-05	0.000325	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GLP1R—pancreatic cancer	1.85e-05	0.000325	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—DPYD—pancreatic cancer	1.82e-05	0.00032	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—EGFR—pancreatic cancer	1.82e-05	0.000319	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.77e-05	0.000311	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	1.73e-05	0.000303	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CD44—pancreatic cancer	1.72e-05	0.000302	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—KRAS—pancreatic cancer	1.72e-05	0.000301	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.71e-05	0.0003	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.68e-05	0.000295	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.67e-05	0.000293	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.65e-05	0.00029	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GCG—pancreatic cancer	1.65e-05	0.000289	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CD44—pancreatic cancer	1.58e-05	0.000277	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PIK3CA—pancreatic cancer	1.58e-05	0.000277	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—STK11—pancreatic cancer	1.55e-05	0.000272	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—TP53—pancreatic cancer	1.53e-05	0.000268	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GCG—pancreatic cancer	1.52e-05	0.000266	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.51e-05	0.000264	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—HRAS—pancreatic cancer	1.46e-05	0.000256	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.46e-05	0.000255	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.43e-05	0.000251	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—STK11—pancreatic cancer	1.43e-05	0.00025	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.41e-05	0.000247	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CD44—pancreatic cancer	1.34e-05	0.000235	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.34e-05	0.000234	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—TYMS—pancreatic cancer	1.33e-05	0.000234	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.31e-05	0.00023	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.3e-05	0.000228	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—AKT1—pancreatic cancer	1.29e-05	0.000226	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GCG—pancreatic cancer	1.28e-05	0.000225	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—TYMS—pancreatic cancer	1.23e-05	0.000215	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—STK11—pancreatic cancer	1.21e-05	0.000212	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.13e-05	0.000199	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—APOE—pancreatic cancer	1.08e-05	0.00019	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—TYMS—pancreatic cancer	1.04e-05	0.000182	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CD44—pancreatic cancer	1.03e-05	0.000181	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.03e-05	0.00018	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—APOE—pancreatic cancer	9.97e-06	0.000175	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GCG—pancreatic cancer	9.91e-06	0.000174	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	9.79e-06	0.000172	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PPARG—pancreatic cancer	9.45e-06	0.000166	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—STK11—pancreatic cancer	9.32e-06	0.000163	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	9e-06	0.000158	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PPARG—pancreatic cancer	8.69e-06	0.000152	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	8.6e-06	0.000151	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—APOE—pancreatic cancer	8.45e-06	0.000148	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—TYMS—pancreatic cancer	8.02e-06	0.000141	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	8e-06	0.00014	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	7.91e-06	0.000139	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	7.63e-06	0.000134	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	7.5e-06	0.000131	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PTGS2—pancreatic cancer	7.43e-06	0.00013	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PPARG—pancreatic cancer	7.36e-06	0.000129	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	6.9e-06	0.000121	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	6.83e-06	0.00012	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	6.7e-06	0.000118	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—APOE—pancreatic cancer	6.52e-06	0.000114	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PTEN—pancreatic cancer	6.48e-06	0.000114	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PTEN—pancreatic cancer	5.96e-06	0.000105	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	5.89e-06	0.000103	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	5.84e-06	0.000102	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PTGS2—pancreatic cancer	5.79e-06	0.000102	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PPARG—pancreatic cancer	5.68e-06	9.96e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	5.17e-06	9.07e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PTEN—pancreatic cancer	5.05e-06	8.85e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	4.57e-06	8.02e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	4.51e-06	7.91e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	4.47e-06	7.84e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	4.2e-06	7.37e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PTEN—pancreatic cancer	3.9e-06	6.83e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—AKT1—pancreatic cancer	3.73e-06	6.55e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	3.56e-06	6.25e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—AKT1—pancreatic cancer	3.43e-06	6.02e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—AKT1—pancreatic cancer	2.91e-06	5.1e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	2.75e-06	4.82e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—AKT1—pancreatic cancer	2.25e-06	3.94e-05	CbGpPWpGaD
